LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 304, Issue 12, 2013, Pages

  Barabutis, Nektarios ^a   Handa, Vaishali ^a   Dimitropoulou, Christiana ^a   Rafikov, Ruslan ^a   Snead, Connie ^a   Kumar, Sanjiv ^a   Joshi, Atul ^a   Thangjam, Gagan ^a   Fulton, David ^a   Black, Stephen M ^a   Patel, Vijay ^a   Catravas, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Endothelial cells; Hsp90; Human; LPS; Posttranslational modifications

Indexed keywords

HEAT SHOCK PROTEIN 90; LIPOPOLYSACCHARIDE; PROTEIN KINASE P60; TANESPIMYCIN; TYROSINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; BENZOQUINONE DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HSP90AB1 PROTEIN, HUMAN; HSP90ALPHA PROTEIN, HUMAN; MACROCYCLIC LACTAM; NOS3 PROTEIN, HUMAN; PYRIMIDINE DERIVATIVE; SMALL INTERFERING RNA;

ADENOVIRUS; ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; COW; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; MASS SPECTROMETRY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; VASCULAR ENDOTHELIUM; ANIMAL; C57BL MOUSE; CATTLE; CELL CULTURE; DRUG EFFECT; ENDOTHELIUM CELL; GENETICS; HSP90; IMMUNOLOGY; LUNG; METABOLISM; PHOSPHORYLATION; POSTTRANSLATIONAL MODIFICATIONS; PROTEIN BINDING; SIGNAL TRANSDUCTION;

ENDOTHELIAL CELLS; HSP90; HUMAN; LPS; POSTTRANSLATIONAL MODIFICATIONS;

ANIMALS; BENZOQUINONES; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS PP60(C-SRC); PYRIMIDINES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TYROSINE;

EID: 84879160939     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00419.2012     Document Type: Article

References (52)

1. Adinolfi E, Kim M, Young MT, Di Virgilio F, Surprenant A. Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors. J Biol Chem 278: 37344-37351, 2003.
2. Antonov A, Snead C, Gorshkov B, Antonova GN, Verin AD, Catravas JD. Heat shock protein 90 inhibitors protect and restore pulmonary endothelial barrier function. Am J Respir Cell Mol Biol 39: 551-559, 2008.
3. Barabutis N, Catravas JD. Anti-inflammatory activity of Hsp90 inhibitors in the human vasculature. Med Surg Urol 2: e104, 2013.
4. Basso AD, Solit DB, Munster PN, Rosen N. Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. Oncogene 21: 1159-1166, 2002.
5. Catravas JD, Snead C, Dimitropoulou C, Chang AS, Lucas R, Verin AD, Black SM. Harvesting, identification and barrier function of human lung microvascular endothelial cells. Vascul Pharmacol 52: 175-181, 2010.
6. Chandarlapaty S, Scaltriti M, Angelini P, Ye Q, Guzman M, Hudis CA, Norton L, Solit DB, Arribas J, Baselga J, Rosen N. Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth. Oncogene 29: 325-334, 2010.
7. Chatterjee A, Snead C, Yetik-Anacak G, Antonova G, Zeng J, Catravas JD. Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability. Am J Physiol Lung Cell Mol Physiol 294: L755-L763, 2008.
8. Check J, Byrd CL, Menio J, Rippe RA, Hines IN, Wheeler MD. Src kinase participates in LPS-induced activation of NADPH oxidase. Mol Immunol 47: 756-762, 2010.
9. Chen YJ, Hsieh MY, Chang MY, Chen HC, Jan MS, Maa MC, Leu TH. Eps8 protein facilitates phagocytosis by increasing TLR4-MyD88 protein interaction in lipopolysaccharide-stimulated macrophages. J Biol Chem 287: 18806-18819, 2012.
10. Crevecoeur J, Merville MP, Piette J, Gloire G. Geldanamycin inhibits tyrosine phosphorylation-dependent NF-κβ activation. Biochem Pharmacol 75: 2183-2191, 2008.
11. Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 79: 129-168, 1998.
12. Dezwaan DC, Freeman BC. HSP90: the Rosetta stone for cellular protein dynamics? Cell Cycle 7: 1006-1012, 2008.
13. dos Santos CC, Han B, Andrade CF, Bai X, Uhlig S, Hubmayr R, Tsang M, Lodyga M, Keshavjee S, Slutsky AS, Liu M. DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNFα, LPS, and cyclic stretch. Physiol Genomics 19: 331-342, 2004.
14. Duval M, Le Boeuf F, Huot J, Gratton JP. Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase. Mol Biol Cell 18: 4659-4668, 2007.
15. Fulton D, Church JE, Ruan L, Li C, Sood SG, Kemp BE, Jennings IG, Venema RC. Src kinase activates endothelial nitric-oxide synthase by phosphorylating Tyr-83. J Biol Chem 280: 35943-35952, 2005.
16. Graf C, Stankiewicz M, Kramer G, Mayer MP. Spatially and kinetically resolved changes in the conformational dynamics of the Hsp90 chaperone machine. EMBO J 28: 602-613, 2009.
17. Grammatikakis N, Vultur A, Ramana CV, Siganou A, Schweinfest CW, Watson DK, Raptis L. The role of Hsp90N, a new member of the Hsp90 family, in signal transduction and neoplastic transformation. J Biol Chem 277: 8312-8320, 2002.
18. Grandel U, Grimminger F. Endothelial responses to bacterial toxins in sepsis. Crit Rev Immunol 23: 267-299, 2003.
19. Hsieh HL, Wang HH, Wu CY, Tung WH, Yang CM. Lipoteichoic acid induces matrix metalloproteinase-9 expression via transactivation of PDGF receptors and NF-κβ activation in rat brain astrocytes. Neurotox Res 17: 344-359, 2010.
20. Kaplan KB, Li R. A prescription for 'stress'-the role of Hsp90 in genome stability and cellular adaptation. Trends Cell Biol 2012.
21. Kovacs JJ, Murphy PJ, Gaillard S, Zhao X, Wu JT, Nicchitta CV, Yoshida M, Toft DO, Pratt WB, Yao TP. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell 18: 601-607, 2005.
22. Lees-Miller SP, Anderson CW. Two human 90-kDa heat shock proteins are phosphorylated in vivo at conserved serines that are phosphorylated in vitro by casein kinase II. J Biol Chem 264: 2431-2437, 1989.
23. Leu TH, Charoenfuprasert S, Yen CK, Fan CW, Maa MC. Lipopolysaccharide- induced c-Src expression plays a role in nitric oxide and TNFα secretion in macrophages. Mol Immunol 43: 308-316, 2006.
24. Lucas R, Verin AD, Black SM, Catravas JD. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol 77: 1763-1772, 2009.
25. Martinez-Ruiz A, Villanueva L, Gonzalez de Orduna C, Lopez-Ferrer D, Higueras MA, Tarin C, Rodriguez-Crespo I, Vazquez J, Lamas S. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc Natl Acad Sci USA 102: 8525-8530, 2005.
26. Mimnaugh EG, Worland PJ, Whitesell L, Neckers LM. Possible role for serine/threonine phosphorylation in the regulation of the heteroprotein complex between the hsp90 stress protein and the pp60v-src tyrosine kinase. J Biol Chem 270: 28654-28659, 1995.
27. Miyata Y. Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery. Cell Mol Life Sci 66: 1840-1849, 2009.
28. Mollapour M, Neckers L. Post-translational modifications of Hsp90 and their contributions to chaperone regulation. Biochim Biophys Acta 1823: 648-655, 2012.
29. Mollapour M, Tsutsumi S, Neckers L. Hsp90 phosphorylation, Wee1 and the cell cycle. Cell Cycle 9: 2310-2316, 2010.
30. Mollapour M, Tsutsumi S, Truman AW, Xu W, Vaughan CK, Beebe K, Konstantinova A, Vourganti S, Panaretou B, Piper PW, Trepel JB, Prodromou C, Pearl LH, Neckers L. Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity. Mol Cell 41: 672-681, 2011.
31. Morra G, Verkhivker G, Colombo G. Modeling signal propagation mechanisms and ligand-based conformational dynamics of the Hsp90 molecular chaperone full-length dimer. PLoS Comput Biol 5: e1000323, 2009.
32. Murata M, Miura Y, Hashiramoto A, Kitamura H, Kawasaki H, Shiozawa K, Yoshiya S, Baba H, Chihara K, Shiozawa S. Heat shock protein 90 is required for increased DNA binding activity of activator protein-1, a heterodimer of Fos/JunD, in rheumatoid synovial cells under inflammatory stimuli. Int J Mol Med 15: 649-653, 2005.
33. Pearl LH, Prodromou C. Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem 75: 271-294, 2006.
34. Qin S, Ni M, Wang X, Maurier-Mahe F, Shurland DL, Rodrigues GA. Inhibition of RPE cell sterile inflammatory responses and endotoxininduced uveitis by a cell-impermeable HSP90 inhibitor. Exp Eye Res 93: 889-897, 2011.
35. Retzlaff M, Stahl M, Eberl HC, Lagleder S, Beck J, Kessler H, Buchner J. Hsp90 is regulated by a switch point in the C-terminal domain. EMBO Rep 10: 1147-1153, 2009.
36. Samant RS, Clarke PA, Workman P. The expanding proteome of the molecular chaperone HSP90. Cell Cycle 11: 1301-1308, 2012.
37. Scroggins BT, Robzyk K, Wang D, Marcu MG, Tsutsumi S, Beebe K, Cotter RJ, Felts S, Toft D, Karnitz L, Rosen N, Neckers L. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol Cell 25: 151-159, 2007.
38. Severgnini M, Takahashi S, Tu P, Perides G, Homer RJ, Jhung JW, Bhavsar D, Cochran BH, Simon AR. Inhibition of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung injury. Am J Respir Crit Care Med 171: 858-867, 2005.
39. Shimp SK 3rd, Chafin CB, Regna NL, Hammond SE, Read MA, Caudell DL, Rylander M, Reilly CM. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus. Cell Mol Immunol 9: 255-266, 2012.
40. Shimp SK 3rd, Parson CD, Regna NL, Thomas AN, Chafin CB, Reilly CM, Rylander MN. HSP90 inhibition by 17-DMAG reduces inflammation in J774 macrophages through suppression of Akt and nuclear factor- κβ pathways. Inflamm Res 61: 521-533, 2012.
41. Soroka J, Buchner J. Mechanistic aspects of the Hsp90 phosphoregulation. Cell Cycle 11: 1870-1871, 2012.
42. Soroka J, Wandinger SK, Mausbacher N, Schreiber T, Richter K, Daub H, Buchner J. Conformational switching of the molecular chaperone Hsp90 via regulated phosphorylation. Mol Cell 45: 517-528, 2012.
43. Sreedhar AS, Kalmar E, Csermely P, Shen YF. Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett 562: 11-15, 2004.
44. Su SC, Hua KF, Lee H, Chao LK, Tan SK, Yang SF, Hsu HY. LTA and LPS mediated activation of protein kinases in the regulation of inflammatory cytokines expression in macrophages. Clin Chim Acta 374: 106-115, 2006.
45. Sumimoto H, Hata K, Mizuki K, Ito T, Kage Y, Sakaki Y, Fukumaki Y, Nakamura M, Takeshige K. Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase. J Biol Chem 271: 22152-22158, 1996.
46. Tang CH, Hsu CJ, Yang WH, Fong YC. Lipoteichoic acid enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, PKCδ and c-Src dependent pathways. Biochem Pharmacol 79: 1648-1657, 2010.
47. Tiruppathi C, Malik AB, Del Vecchio PJ, Keese CR, Giaever I. Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function. Proc Natl Acad Sci USA 89: 7919-7923, 1992.
48. Trepel J, Mollapour M, Giaccone G, Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10: 537-549, 2010.
49. Wandinger SK, Suhre MH, Wegele H, Buchner J. The phosphatase Ppt1 is a dedicated regulator of the molecular chaperone Hsp90. EMBO J 25: 367-376, 2006.
50. Xu W, Mollapour M, Prodromou C, Wang S, Scroggins BT, Palchick Z, Beebe K, Siderius M, Lee MJ, Couvillon A, Trepel JB, Miyata Y, Matts R, Neckers L. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50 (CDC37)-AHA1 chaperone machine. Mol Cell 47: 434-443, 2012.
51. Yun TJ, Harning EK, Giza K, Rabah D, Li P, Arndt JW, Luchetti D, Biamonte MA, Shi J, Lundgren K, Manning A, Kehry MR. EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity. J Immunol 186: 563-575, 2011.
52. Zhao YG, Gilmore R, Leone G, Coffey MC, Weber B, Lee PW. Hsp90 phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein. J Biol Chem 276: 32822-32827, 2001.